Effect of ethnic origin (Caucasians versus Turks) on the prevalence of rheumatic diseases: a WHO-ILAR COPCORD urban study in Iran

Abstract

The objective of this study was to compare the prevalence of musculoskeletal complaints and rheumatic disorders in Caucasians and Turks in an identical environment. Subjects were selected randomly for an interview from Tehran's 22 districts. The Community Oriented Program for Control of Rheumatic Diseases questionnaire was filled in, positive cases were examined, and if needed, laboratory or X-ray tests were performed. A total of 4,096 houses were visited, and 10,291 persons were interviewed. They were 71.4% Caucasians and 23.1% Turks with similar distribution of age and gender. Musculoskeletal complaints of the past 7 days were detected in 40.8% of Caucasians and 45.5% of Turks (p < 0.001). In Caucasians, the total of musculoskeletal complaints in men was 33.8% (95% CI, 31.4-36.2%) versus 48.3% in women (95% CI, 45.7-50.8%). In Turks, the total of musculoskeletal complaints in men was 36.6% (95% CI, 32.2-41.1%) versus 55.8% in women (95% CI, 55.8-60.6%). The data of Caucasians versus Turks were as follows: knee pain 20.2% (95% CI, 18.2-22.1) versus 24.1% (95% CI, 20.5-27.6), with p < 0.001; dorso-lumbar spine pain 15.1% (95% CI, 13.6-16.6) versus 18.4% (95% CI, 15.1-21.8), with p < 0.001; shoulder pain 10.7% (95% CI, 9.4-11.9) versus 12.3% (95% CI, 9.7-14.8), with p = 0.025; osteoarthritis 14.1% (95% CI, 12.8-15.2) versus 16.4% (95% CI, 14.3-18.6), p = 0.04; and knee osteoarthritis 12.3% (95% CI, 11.8-14.1) versus 15.3% (95% CI, 13.3-17.4), with p < 0.001). There were no significant differences regarding the prevalence of soft tissue rheumatism, rheumatoid arthritis, ankylosing spondylitis, Behcet's disease, fibromyalgia, and gout. Although musculoskeletal complaints were more frequent in Turks than in Caucasians, the prevalence of rheumatic disorders was rather similar except for knee osteoarthritis.

Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution?

“…In one study from the UAE, DMARDs were being used by only 43 % of patients at presentation and only 50 % of patients with symptoms for ≥1 year, with a lag time to use of first DMARD of 1.6 years [20]. Results were similar in Kenya, with 47 % of patients receiving DMARDs-most commonly methotrexate or steroids alone or in combination-or non-steroidal antiinflammatory drugs (NSAIDs) [16]. In Morocco, although 91-98 % of patients seen at rheumatology departments were receiving DMARDs, few were receiving treatment with biologics [26].…”

Serum adenosine deaminase may predict disease activity in rheumatoid arthritis

“…Rheumatoid arthritis (RA) is one of the most common causes of chronic inflammatory arthritis [1][2][3][4]. Early diagnosis and proper management is necessary for slowing the degenerative changes in synovium and joint cartilage.…”

Work-Related Musculoskeletal Disorders and the Relationship to Ethnicity

“…Joshi and Chopra [18] and Davatchi et al [19] investigate the prevalence of MSK diseases in India and Iran, respectively, through the implementation of the Community Orientated Program for the Control of Rheumatic Diseases (COPCORD). In the irst case, people living in urban area had less prevalence of MSK diseases, in comparison to the people in rural area.…”